메뉴 건너뛰기




Volumn 2015, Issue 23, 2015, Pages 3879-3891

Towards Selective Light-Activated RuII-Based Prodrug Candidates

Author keywords

Antitumor agents; Medicinal chemistry; Peptides; Photoactivated chemotherapy; Ruthenium

Indexed keywords

CANCER CELLS; CELL DEATH; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DRUG PRODUCTS; IRRADIATION; LANTHANUM COMPOUNDS; OXYGEN; PEPTIDES; PHOTODYNAMIC THERAPY; RUTHENIUM COMPOUNDS; TARGETED DRUG DELIVERY; TISSUE;

EID: 84939254484     PISSN: 14341948     EISSN: 10990682     Source Type: Journal    
DOI: 10.1002/ejic.201500602     Document Type: Article
Times cited : (54)

References (69)
  • 33
    • 85153160264 scopus 로고    scopus 로고
    • http://www.stockhouse.com/news/press-releases/2015/01/15/theralase-identifies-lead-photo-dynamic-compound-for-human-clinical-trials.
  • 37
    • 84867032999 scopus 로고    scopus 로고
    • references therein
    • N. L. Kilah, E. Meggers, Aust. J. Chem. 2012, 65, 1325-1332 and references therein.
    • (2012) Aust. J. Chem. , vol.65 , pp. 1325-1332
    • Kilah, N.L.1    Meggers, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.